Can you stay on 2.5mg Mounjaro for weight loss long-term?

You've started at 2.5mg and it's going fine, so why change anything?

It's a reasonable thought. You feel better than you expected, the nausea has been manageable, and you're wondering whether the dose doing this is already enough. Many people feel this way around the three- or four-week mark. The honest answer is that 2.5mg is almost certainly not driving the weight loss you're hoping for. It is specifically licensed as a four-week tolerability dose: the body is meeting tirzepatide for the first time, and the lower concentration is there to reduce the GI side effects that can catch people off-guard at higher levels.

Tirzepatide works by activating both GIP and GLP-1 receptors, slowing gastric emptying and reducing appetite. At 2.5mg, that mechanism is present but the signal is weaker than at the doses where clinical evidence is strongest. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% over 72 weeks at the 15mg dose, but those participants had titrated through the lower doses to reach it. The 2.5mg phase was a stepping stone, not a destination. If you're weighing up how the full dosing journey works, the overview of Mounjaro dosing for weight loss covers the licensed schedule in more detail.

None of this means your 2.5mg experience doesn't count. It tells you a great deal about how your body is responding, and that information is genuinely useful to the prescriber reviewing your next step.

When staying at 2.5mg might be the right clinical call, at least for now

There are situations where a prescriber may recommend remaining at 2.5mg for longer than the standard four weeks. If GI side effects are still significant at the end of the first month, pushing to 5mg immediately can make things worse rather than better. Slowing the titration schedule is a recognised clinical approach. Some people with other health conditions, or who are taking certain medicines alongside Mounjaro, may need a more cautious pace. That is a medical decision, not one to make unilaterally.

What isn't supported by the licensed guidance is choosing to stay at 2.5mg indefinitely because it feels comfortable, or because you've heard that a lower dose is gentler long-term. The NHS tirzepatide information page is clear that the starting dose is not the treatment dose. Comfort at 2.5mg is welcome news, it usually predicts good tolerability at higher doses too. Think of the first pen's job as settling your system, not as the main event.

If you're curious about what the next rung looks like, the 5mg Mounjaro page covers what to expect at that dose, and there's also dedicated guidance on whether staying on 5mg for weight loss is a viable longer-term option.

What your prescriber is actually looking at before any dose decision

At a clinical review before titration, the questions are roughly these: how have you tolerated the current dose? Any persistent nausea, vomiting, or stomach pain worth flagging? Has your weight started to shift, even modestly? Are there any new health changes since the last review? The prescriber at a service like ours reads your answers personally, your notes aren't processed by a system and routed automatically. A real clinician makes the call.

This is also the moment to raise any concerns about moving up. If you're anxious about the jump to 5mg, say so. Prescribers can adjust the titration timeline when there's a clinical reason to. What they can't responsibly do is leave someone at 2.5mg for months with no review and no plan, that would mean missing the weight-loss benefit the medicine is licensed to provide. If the titration continues and you find yourself wondering whether 7.5mg could be the right long-term dose for you, that's also a question worth bringing to your review.

For context on what private treatment involves financially, the Mounjaro cost page sets out what to expect. And if you're weighing up 2.5mg specifically before starting, the detail on what to expect from the 2.5mg phase is worth a read.

The short answer, put plainly

Staying on 2.5mg Mounjaro for weight loss long-term is not what the licence supports, and it is unlikely to produce the outcomes that brought you to treatment in the first place. The dose is a starting point. Titration (done at the right pace for you, guided by a prescriber) is how the medicine delivers its effect. If you've had a smooth first month and you're ready for the next step, that's exactly what the review process is for.

Some people find they lose very little at 2.5mg and worry the medicine isn't working. Others see modest early changes and want to preserve that momentum. Either way, the path forward is the same: a proper clinical conversation about where you are and what comes next. Our team at nume (sorry, at nume) reviews every patient's progress before each repeat order, so no prescription continues on autopilot. If you'd like to explore whether treatment is right for you, check your eligibility with a free consultation.